1. Home
  2. Analysis
  3. Axid-ar
  4. Allopurinol

Axid ar and Allopurinol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 13 people who take Axid ar and Allopurinol. Common interactions include chronic kidney disease among females, and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Axid ar and Allopurinol have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 04, 2023

13 people who take Axid ar and Allopurinol together, and have interactions are studied.

What is Axid ar?

Axid ar has active ingredients of nizatidine. Currently, eHealthMe is studying from 237 Axid ar users.

What is Allopurinol?

Allopurinol has active ingredients of allopurinol. It is used in gout. Currently, eHealthMe is studying from 181,418 Allopurinol users.

Number of Axid ar and Allopurinol reports submitted per year:

Axid ar and Allopurinol drug interactions.

Common Axid Ar and Allopurinol drug interactions by gender *:

female:

  1. Chronic kidney disease
  2. Gastrooesophageal reflux disease
  3. Nephrogenic anaemia

male:

  1. Chronic kidney disease
  2. Renal failure
  3. Rebound effect
  4. Nephrolithiasis
  5. Renal injury
  6. Nephrogenic anaemia
  7. Blindness
  8. Diabetic retinopathy
  9. Eye disorder
  10. Glaucoma

Common Axid Ar and Allopurinol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary
  3. Renal failure

60+:

  1. Chronic kidney disease
  2. Blindness
  3. Diabetic retinopathy
  4. Eye disorder
  5. Gastrooesophageal reflux disease
  6. Glaucoma
  7. Nephrogenic anaemia

Common conditions people have *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 84.62%
  2. High Blood Cholesterol: 6 people, 46.15%
  3. Pain: 6 people, 46.15%
  4. High Blood Pressure: 5 people, 38.46%
  5. Cardiac Disorder: 2 people, 15.38%
  6. Indigestion: 2 people, 15.38%
  7. Thyroid Diseases: 1 person, 7.69%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%
  9. Depression: 1 person, 7.69%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Axid ar and Allopurinol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Axid ar drug interactions:

Browse interactions between Axid ar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Allopurinol drug interactions:

Browse interactions between Allopurinol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nizatidine and allopurinol (the active ingredients of Axid ar and Allopurinol, respectively), and Axid ar and Allopurinol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Axid ar and Allopurinol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.